Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 GuidanceRALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to the fourth quarter and full year 2025 are preliminary, unaudited, and subject to final review and adjustment.
Lumexa Imaging's Steady Debut Signals Maturing IPO Market Amidst 2025 BoomNew York, NY – December 11, 2025 – Lumexa Imaging Holdings (
NASDAQ: LMRI), a leading provider of diagnostic imaging services, made its public market debut today, pricing its initial public offering (IPO) at $18.50 per share. The successful launch, which raised approximately $463 million, positions Lumexa as a significant new entrant
